New study aims to boost breast cancer treatment success with personalized approach

This study is for women with a specific type of early breast cancer (HR+/HER2+). The goal is to see if giving a personalized treatment plan before surgery can improve outcomes. Doctors will check how well the tumor responds to initial therapy and adjust the regimen accordingly, potentially adding hormone therapy for those who don't respond well. The study involves 60 participants and aims to increase the chance of eliminating all cancer cells before surgery.